ICAS Screen Based on RIC

Launched by XUANWU HOSPITAL, BEIJING · Sep 22, 2024

Keywords

ClinConnect Summary

This clinical trial, called ICAS Screen Based on RIC, is focused on finding a new way to screen for a condition known as intracranial atherosclerosis (ICAS), which can lead to strokes. Strokes caused by ICAS can be more severe and may require longer hospital stays. The goal of the study is to use images of the retina (the back part of the eye) to identify individuals at risk for ICAS, making screening easier and more accessible for everyone, especially in primary healthcare settings.

To participate in this trial, individuals must be 18 years or older and have had a specific imaging test of the head and neck recently. They should be able to follow up for an eye exam and provide consent to join the study. Participants can expect to undergo a non-invasive eye exam that uses retinal imaging, which is simple and painless. This study is crucial as it aims to improve early detection of ICAS, potentially reducing the risk of strokes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The age is above 18 years old;
• • 2. Complete head and neck DSA, CTA, MRA or HR-MRI examination within 2 weeks;
• • 3. He/She can cooperate with follow-up fundus examination with free movement;
• • 4. Signed informed consent.
• Exclusion Criteria:
• • 1. Poor quality of fundus images;
• • 2. With intracranial mass lesions;
• • 3. With severe heart, liver and kidney diseases;
• • 4. With pregnancy and lactation.